Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bicara Therapeutics Inc. | 154,555 | reported | 21 May 2026 | tx 42+235,400−220,800 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 3.79 USD | 10b5-1 |
| 21 May 2026 | SALE | Bicara Therapeutics Inc. | 9,200 | 20.42 USD | 10b5-1 |
| 21 May 2026 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 0.00 USD | 10b5-1deriv |
| 21 Apr 2026 | SALE | Bicara Therapeutics Inc. | 9,200 | 23.00 USD | |
| 21 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 3.79 USD | |
| 21 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 0.00 USD | deriv |
| 23 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 3.79 USD | |
| 23 Mar 2026 | SALE | Bicara Therapeutics Inc. | 9,200 | 18.52 USD | |
| 23 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 0.00 USD | deriv |
| 03 Mar 2026 | SALE | Bicara Therapeutics Inc. | 13,555 | 18.22 USD | |
| 04 Mar 2026 | SALE | Bicara Therapeutics Inc. | 2,963 | 18.25 USD | |
| 04 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 2,963 | 3.79 USD | |
| 03 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 6,237 | 3.79 USD | |
| 03 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 7,318 | 3.79 USD | |
| 04 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 2,963 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 6,237 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 7,318 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Bicara Therapeutics Inc. | 125,000 | 0.00 USD | deriv |
| 22 Jan 2026 | EXERCISE | Bicara Therapeutics Inc. | 1,882 | 3.79 USD | |
| 22 Jan 2026 | SALE | Bicara Therapeutics Inc. | 1,882 | 18.15 USD | |
| 22 Jan 2026 | EXERCISE | Bicara Therapeutics Inc. | 1,882 | 0.00 USD | deriv |
| 22 Dec 2025 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 3.79 USD | |
| 22 Dec 2025 | SALE | Bicara Therapeutics Inc. | 9,200 | 18.31 USD | |
| 22 Dec 2025 | EXERCISE | Bicara Therapeutics Inc. | 9,200 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | Bicara Therapeutics Inc. | 605 | 3.79 USD |